Consistent with the present findings, we previously reported that knocking down TRPV4 suppressed colon cancer cell growth via PTEN activation, and inhibited invasiveness by blocking ZEB1 signaling (Liu et al., 2019; Zhang et al., 2021). Here, PTEN is linked to colonic neoplasm.